Dosing to rash: A phase II trial of the first-line erlotinib for patients with advanced non-small-cell lung cancer an Eastern Cooperative Oncology Group Study (E3503).
European Journal of Cancer.
Times cited: 18
Maintenance etidronate in the prevention of malignancy-associated hypercalcemia.
Archives of Internal Medicine.
Times cited: 12